Cargando…

A Paradigm to Discover Biomarkers Associated With Chronic Kidney Disease Progression

Biomarker discovery in the field of risk prediction in chronic kidney disease (CKD) embraces the prospect of improving our ability to risk stratify future adverse outcomes and thereby guide patient care in a new era of personalised medicine. However, many studies that report biomarkers predictive of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Ibrahim, Ibrahim, Sara T, Chinnadurai, Rajkumar, Green, Darren, Taal, Maarten, Whetton, Tony D, Kalra, Philip A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716058/ https://www.ncbi.nlm.nih.gov/pubmed/33311975 http://dx.doi.org/10.1177/1177271920976146

Ejemplares similares

Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease
por: Ali, Ibrahim, et al.
Publicado: (2020)

Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression
por: Ali, Ibrahim, et al.
Publicado: (2021)

Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2020)

Treatment of anaemia in end-stage renal disease: A double-edged iron sword?
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

Genetic polymorphism in C3 is associated with progression in chronic kidney disease (CKD) patients with IgA nephropathy but not in other causes of CKD
por: Ibrahim, Sara T., et al.
Publicado: (2020)

Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study
por: Fenton, Anthony, et al.
Publicado: (2020)

Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study
por: Tollitt, James, et al.
Publicado: (2019)

Physiologically‐Based Pharmacokinetic Modelling of Creatinine‐Drug Interactions in the Chronic Kidney Disease Population
por: Takita, Hiroyuki, et al.
Publicado: (2020)

Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

Obesity and chronic kidney disease: A current review
por: Nawaz, Saira, et al.
Publicado: (2022)

Proteomic signature associated with chronic kidney disease (CKD) progression identified by data-independent acquisition mass spectrometry
por: Ramírez Medina, Carlos R., et al.
Publicado: (2023)

Longitudinal change in c-terminal fibroblast growth factor 23 and outcomes in patients with advanced chronic kidney disease
por: Alderson, Helen V., et al.
Publicado: (2021)

New-Onset and Relapsed Kidney Histopathology Following COVID-19 Vaccination: A Systematic Review
por: Wu, Henry H. L., et al.
Publicado: (2021)

The role of patiromer: Comparing OPAL-HK data with untreated real-world patients in the United Kingdom—A retrospective, propensity-matched analysis
por: Ali, Ibrahim, et al.
Publicado: (2020)

A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
por: Eddington, Helen, et al.
Publicado: (2021)

Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
por: Chinnadurai, Rajkumar, et al.
Publicado: (2021)

Intrinsic Kidney Pathology Following COVID-19 Infection in Children and Adolescents: A Systematic Review
por: Wu, Henry H. L., et al.
Publicado: (2021)

Intrinsic Kidney Pathology in Children and Adolescents Following COVID-19 Vaccination: A Systematic Review
por: Wu, Henry H. L., et al.
Publicado: (2022)

Does the biomarker search paradigm need re-booting?
por: Hurst, Robert E
Publicado: (2009)

Screening for Chronic Kidney Disease: Preventing Harm or Harming the Healthy?
por: Taal, Maarten W.
Publicado: (2012)

Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis
por: Chinnadurai, Rajkumar, et al.
Publicado: (2019)

Using Prior Knowledge on Systems Through PBPK to Gain Further Insight into Routine Clinical Data on Trough Concentrations: The Case of Tacrolimus in Chronic Kidney Disease
por: El-Khateeb, Eman, et al.
Publicado: (2023)

Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression
por: Kontos, Christos K.
Publicado: (2015)

What is the value of multidisciplinary care for chronic kidney disease?
por: Fluck, Richard J., et al.
Publicado: (2018)

The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease
por: Sykes, Lynne, et al.
Publicado: (2019)

Does previous stroke modify the relationship between inflammatory biomarkers and clinical endpoints in CKD patients?
por: Tollitt, James, et al.
Publicado: (2022)

Discovering chronic pain treatments: better animal models might help us get there
por: Taylor, Norman E., et al.
Publicado: (2023)

Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review
por: Jeyalan, Vishnu, et al.
Publicado: (2021)

The epidemiology and evolution of IgA nephropathy over two decades: A single centre experience
por: Storrar, Joshua, et al.
Publicado: (2022)

Paradigm Shift or Shifting Paradigm for Type 1 Diabetes
por: Nakayama, Maki, et al.
Publicado: (2012)

Breaking old and new paradigms regarding urinary sodium in acute kidney injury diagnosis and management
por: Maciel, Alexandre Toledo
Publicado: (2013)

Kidney Transplant-Associated Viral Infection Rates and Outcomes in a Single-Centre Cohort
por: Pullerits, Kairi, et al.
Publicado: (2022)

Comparing the impact of older age on outcome in chronic kidney disease of different etiologies: a prospective cohort study
por: Raman, Maharajan, et al.
Publicado: (2018)

Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression
por: Kuro-o, Makoto
Publicado: (2023)

Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all
por: Bolignano, Davide, et al.
Publicado: (2014)

Urinary cell‐free extrachromosomal circular DNAs: A possible biomarker for chronic kidney disease
por: Demirci, Selami
Publicado: (2022)

A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility
por: Ali, Ibrahim, et al.
Publicado: (2021)

Beyond Discovering the Viral Agents of Acute Gastroenteritis
por: Glass, Roger
Publicado: (2013)

Kidney Transplantation in Septuagenarians: 70 Is the New 60!
por: Hebert, Sean A., et al.
Publicado: (2019)

Outcomes in dialysis versus conservative care for older patients: A prospective cohort analysis of stage 5 Chronic Kidney Disease
por: Raman, Maharajan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ckgmsk6km80650h8jj030acbfh